CMRA vs. HSTO, BLPH, SXTC, APVO, ADTX, EVFM, SPRC, EVLO, SBFM, and ATHX
Should you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include Histogen (HSTO), Bellerophon Therapeutics (BLPH), China SXT Pharmaceuticals (SXTC), Aptevo Therapeutics (APVO), Aditxt (ADTX), Evofem Biosciences (EVFM), SciSparc (SPRC), Evelo Biosciences (EVLO), Sunshine Biopharma (SBFM), and Athersys (ATHX). These companies are all part of the "pharmaceutical preparations" industry.
Histogen (NASDAQ:HSTO) and Comera Life Sciences (NASDAQ:CMRA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership.
Histogen received 7 more outperform votes than Comera Life Sciences when rated by MarketBeat users.
In the previous week, Comera Life Sciences had 1 more articles in the media than Histogen. MarketBeat recorded 1 mentions for Comera Life Sciences and 0 mentions for Histogen. Comera Life Sciences' average media sentiment score of 0.00 equaled Histogen'saverage media sentiment score.
Histogen has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, Comera Life Sciences has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500.
Comera Life Sciences has a net margin of -904.00% compared to Comera Life Sciences' net margin of -65,142.11%. Histogen's return on equity of 0.00% beat Comera Life Sciences' return on equity.
Histogen has higher revenue and earnings than Comera Life Sciences. Histogen is trading at a lower price-to-earnings ratio than Comera Life Sciences, indicating that it is currently the more affordable of the two stocks.
Summary
Comera Life Sciences beats Histogen on 6 of the 11 factors compared between the two stocks.
Get Comera Life Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CMRA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Comera Life Sciences Competitors List
Related Companies and Tools
